Irene C. Souter, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Insemination, Artificial | 14 | 2024 | 99 | 5.280 |
Why?
|
Infertility, Female | 29 | 2024 | 763 | 4.960 |
Why?
|
Ovulation Induction | 14 | 2024 | 277 | 4.340 |
Why?
|
Infertility | 20 | 2023 | 655 | 3.370 |
Why?
|
Pregnancy Rate | 35 | 2024 | 655 | 3.290 |
Why?
|
Fertilization in Vitro | 34 | 2024 | 1303 | 3.180 |
Why?
|
Anti-Mullerian Hormone | 9 | 2023 | 420 | 2.410 |
Why?
|
Polycystic Ovary Syndrome | 6 | 2024 | 383 | 2.070 |
Why?
|
Fertility Agents, Female | 7 | 2024 | 101 | 2.060 |
Why?
|
Gonadotropins | 5 | 2024 | 241 | 1.840 |
Why?
|
Ovarian Follicle | 13 | 2023 | 244 | 1.790 |
Why?
|
Blastocyst | 11 | 2024 | 433 | 1.760 |
Why?
|
Abortion, Spontaneous | 13 | 2023 | 535 | 1.630 |
Why?
|
Phthalic Acids | 11 | 2023 | 487 | 1.630 |
Why?
|
Embryo Transfer | 12 | 2024 | 527 | 1.550 |
Why?
|
Reproductive Techniques, Assisted | 19 | 2022 | 504 | 1.540 |
Why?
|
Pregnancy Outcome | 24 | 2024 | 2972 | 1.490 |
Why?
|
Environmental Pollutants | 13 | 2024 | 1296 | 1.440 |
Why?
|
Endometrium | 4 | 2024 | 406 | 1.370 |
Why?
|
Clomiphene | 4 | 2024 | 72 | 1.350 |
Why?
|
Follicle Stimulating Hormone | 14 | 2023 | 727 | 1.330 |
Why?
|
Live Birth | 19 | 2024 | 516 | 1.300 |
Why?
|
Phenols | 10 | 2023 | 526 | 1.160 |
Why?
|
Pregnancy | 80 | 2024 | 30256 | 1.090 |
Why?
|
Semen | 8 | 2023 | 349 | 0.920 |
Why?
|
Chorionic Gonadotropin, beta Subunit, Human | 1 | 2024 | 83 | 0.920 |
Why?
|
Diethylhexyl Phthalate | 5 | 2023 | 86 | 0.890 |
Why?
|
Pregnancy, Multiple | 4 | 2019 | 216 | 0.880 |
Why?
|
Embryo Culture Techniques | 3 | 2024 | 84 | 0.880 |
Why?
|
Semen Analysis | 7 | 2023 | 236 | 0.850 |
Why?
|
Thyroid Gland | 3 | 2024 | 1171 | 0.850 |
Why?
|
Follicular Phase | 3 | 2019 | 143 | 0.810 |
Why?
|
Alkanesulfonic Acids | 4 | 2024 | 203 | 0.750 |
Why?
|
Diagnostic Techniques, Obstetrical and Gynecological | 1 | 2020 | 30 | 0.720 |
Why?
|
Anovulation | 1 | 2020 | 54 | 0.710 |
Why?
|
Dairy Products | 3 | 2017 | 490 | 0.640 |
Why?
|
Benzhydryl Compounds | 7 | 2022 | 944 | 0.640 |
Why?
|
Follicular Fluid | 4 | 2023 | 92 | 0.630 |
Why?
|
Fluorocarbons | 4 | 2024 | 506 | 0.610 |
Why?
|
Fertility | 10 | 2023 | 771 | 0.590 |
Why?
|
Embryo Implantation | 8 | 2024 | 272 | 0.550 |
Why?
|
Parabens | 5 | 2023 | 118 | 0.550 |
Why?
|
Decision Support Techniques | 3 | 2022 | 2008 | 0.530 |
Why?
|
Cryopreservation | 5 | 2024 | 733 | 0.490 |
Why?
|
Female | 122 | 2024 | 397192 | 0.480 |
Why?
|
Fathers | 5 | 2024 | 377 | 0.470 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 2 | 2008 | 693 | 0.460 |
Why?
|
Endocrine Disruptors | 2 | 2017 | 265 | 0.460 |
Why?
|
Eating | 3 | 2018 | 1542 | 0.460 |
Why?
|
Adult | 89 | 2024 | 223646 | 0.460 |
Why?
|
Insemination | 3 | 2022 | 18 | 0.450 |
Why?
|
Maternal Exposure | 5 | 2021 | 1096 | 0.450 |
Why?
|
Autoimmunity | 2 | 2020 | 1361 | 0.450 |
Why?
|
Congenital Abnormalities | 1 | 2018 | 703 | 0.430 |
Why?
|
Ovulation | 1 | 2014 | 181 | 0.430 |
Why?
|
Ovary | 4 | 2021 | 965 | 0.430 |
Why?
|
Sperm Injections, Intracytoplasmic | 5 | 2021 | 156 | 0.420 |
Why?
|
Retrospective Studies | 45 | 2024 | 81762 | 0.410 |
Why?
|
Premature Birth | 5 | 2024 | 1829 | 0.410 |
Why?
|
Folic Acid | 4 | 2021 | 1337 | 0.390 |
Why?
|
Dietary Proteins | 1 | 2017 | 960 | 0.380 |
Why?
|
Superovulation | 1 | 2010 | 11 | 0.370 |
Why?
|
Environmental Exposure | 8 | 2024 | 4543 | 0.360 |
Why?
|
Body Mass Index | 6 | 2022 | 13053 | 0.360 |
Why?
|
Birth Weight | 7 | 2024 | 2121 | 0.360 |
Why?
|
Time-Lapse Imaging | 3 | 2020 | 194 | 0.350 |
Why?
|
Humans | 132 | 2024 | 768166 | 0.350 |
Why?
|
Hypothyroidism | 1 | 2014 | 667 | 0.330 |
Why?
|
Thyrotropin | 3 | 2020 | 834 | 0.330 |
Why?
|
Pregnancy Complications | 5 | 2015 | 2973 | 0.320 |
Why?
|
Prolactinoma | 1 | 2010 | 114 | 0.320 |
Why?
|
Hyperprolactinemia | 1 | 2010 | 124 | 0.320 |
Why?
|
Hypertension, Pregnancy-Induced | 3 | 2024 | 529 | 0.310 |
Why?
|
Paternal Exposure | 2 | 2021 | 100 | 0.310 |
Why?
|
Oocyte Retrieval | 5 | 2020 | 162 | 0.310 |
Why?
|
Artificial Intelligence | 5 | 2023 | 2665 | 0.310 |
Why?
|
Placenta Diseases | 2 | 2021 | 199 | 0.300 |
Why?
|
Prospective Studies | 38 | 2023 | 54926 | 0.300 |
Why?
|
Turner Syndrome | 2 | 2021 | 130 | 0.280 |
Why?
|
Preimplantation Diagnosis | 2 | 2023 | 143 | 0.280 |
Why?
|
Chorionic Gonadotropin | 2 | 2023 | 458 | 0.270 |
Why?
|
Fatty Acids, Omega-3 | 3 | 2022 | 1399 | 0.270 |
Why?
|
Embryo, Mammalian | 4 | 2022 | 1676 | 0.270 |
Why?
|
Diet | 9 | 2024 | 8089 | 0.270 |
Why?
|
Steroid 17-alpha-Hydroxylase | 1 | 2006 | 99 | 0.260 |
Why?
|
Fertilization | 3 | 2021 | 197 | 0.250 |
Why?
|
Placenta | 4 | 2022 | 1725 | 0.250 |
Why?
|
Physician-Patient Relations | 1 | 2018 | 3269 | 0.240 |
Why?
|
Hirsutism | 1 | 2004 | 68 | 0.240 |
Why?
|
Birth Rate | 2 | 2024 | 168 | 0.230 |
Why?
|
Hyperandrogenism | 1 | 2004 | 46 | 0.230 |
Why?
|
Models, Chemical | 1 | 2006 | 611 | 0.220 |
Why?
|
Vitrification | 1 | 2024 | 52 | 0.220 |
Why?
|
Oocytes | 5 | 2023 | 1172 | 0.210 |
Why?
|
Infertility, Male | 3 | 2021 | 397 | 0.210 |
Why?
|
Labor, Induced | 1 | 2024 | 156 | 0.210 |
Why?
|
Trophoblasts | 1 | 2024 | 223 | 0.200 |
Why?
|
Contraceptives, Oral | 1 | 2005 | 560 | 0.200 |
Why?
|
Sperm Count | 2 | 2023 | 228 | 0.190 |
Why?
|
Air Pollution | 3 | 2020 | 2374 | 0.190 |
Why?
|
Logistic Models | 9 | 2020 | 13290 | 0.190 |
Why?
|
Menstrual Cycle | 1 | 2005 | 546 | 0.190 |
Why?
|
Air Pollutants | 3 | 2020 | 2916 | 0.190 |
Why?
|
Thyroid Hormones | 2 | 2024 | 407 | 0.190 |
Why?
|
Wounds, Penetrating | 4 | 1996 | 316 | 0.190 |
Why?
|
Laboratory Personnel | 1 | 2021 | 19 | 0.190 |
Why?
|
Coitus | 1 | 2022 | 132 | 0.190 |
Why?
|
Triiodothyronine | 2 | 2024 | 492 | 0.190 |
Why?
|
Pituitary Neoplasms | 1 | 2010 | 1322 | 0.190 |
Why?
|
Preconception Care | 2 | 2019 | 143 | 0.180 |
Why?
|
Semen Preservation | 1 | 2021 | 35 | 0.180 |
Why?
|
Maternal Age | 2 | 2022 | 805 | 0.180 |
Why?
|
Boston | 10 | 2023 | 9374 | 0.180 |
Why?
|
Reproductive Medicine | 1 | 2022 | 99 | 0.180 |
Why?
|
46, XX Disorders of Sex Development | 1 | 2021 | 34 | 0.180 |
Why?
|
Treatment Outcome | 24 | 2022 | 65371 | 0.180 |
Why?
|
Arteriosclerosis | 1 | 2005 | 1055 | 0.180 |
Why?
|
Fetal Resorption | 1 | 2020 | 15 | 0.180 |
Why?
|
Dietary Supplements | 5 | 2021 | 3445 | 0.180 |
Why?
|
Sulfones | 2 | 2021 | 448 | 0.170 |
Why?
|
Healthcare Disparities | 1 | 2016 | 3415 | 0.170 |
Why?
|
Embryology | 1 | 2020 | 30 | 0.170 |
Why?
|
Amino Acids | 1 | 2006 | 1716 | 0.170 |
Why?
|
Maternal Mortality | 2 | 2013 | 310 | 0.170 |
Why?
|
Linear Models | 7 | 2024 | 5884 | 0.160 |
Why?
|
Estradiol | 5 | 2023 | 1951 | 0.160 |
Why?
|
Pregnancy Complications, Neoplastic | 2 | 2012 | 260 | 0.160 |
Why?
|
Karyotyping | 1 | 2021 | 1177 | 0.160 |
Why?
|
Neurofibromatosis 1 | 2 | 2014 | 561 | 0.160 |
Why?
|
Individuality | 1 | 2020 | 307 | 0.160 |
Why?
|
Feeding Behavior | 2 | 2021 | 3205 | 0.160 |
Why?
|
Mercury | 1 | 2021 | 289 | 0.160 |
Why?
|
Genetic Testing | 2 | 2023 | 3591 | 0.150 |
Why?
|
Iodide Peroxidase | 1 | 2020 | 295 | 0.150 |
Why?
|
Bayes Theorem | 3 | 2023 | 2359 | 0.150 |
Why?
|
Women | 1 | 2020 | 225 | 0.150 |
Why?
|
Interleukin-6 | 1 | 2008 | 3228 | 0.150 |
Why?
|
Risk Factors | 21 | 2024 | 74944 | 0.150 |
Why?
|
Thyroglobulin | 1 | 2018 | 111 | 0.150 |
Why?
|
Pregnancy Reduction, Multifetal | 1 | 1998 | 16 | 0.150 |
Why?
|
Embryonic Development | 2 | 2021 | 724 | 0.150 |
Why?
|
Triplets | 1 | 1998 | 42 | 0.150 |
Why?
|
Clothing | 1 | 2018 | 96 | 0.150 |
Why?
|
Flame Retardants | 1 | 2018 | 97 | 0.140 |
Why?
|
Thyroid Function Tests | 1 | 2018 | 289 | 0.140 |
Why?
|
Reproductive History | 1 | 2018 | 210 | 0.140 |
Why?
|
Automobiles | 1 | 2018 | 103 | 0.140 |
Why?
|
Mosaicism | 1 | 2021 | 480 | 0.140 |
Why?
|
Pregnancy, Ectopic | 1 | 2018 | 145 | 0.140 |
Why?
|
Pre-Eclampsia | 3 | 2023 | 1255 | 0.140 |
Why?
|
Pesticide Residues | 1 | 2018 | 95 | 0.140 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2008 | 4352 | 0.140 |
Why?
|
Triclosan | 1 | 2017 | 58 | 0.140 |
Why?
|
Sperm-Ovum Interactions | 1 | 2016 | 24 | 0.140 |
Why?
|
Ozone | 1 | 2020 | 496 | 0.140 |
Why?
|
Spermatozoa | 1 | 2021 | 632 | 0.140 |
Why?
|
25-Hydroxyvitamin D 2 | 1 | 2016 | 40 | 0.140 |
Why?
|
Abdominal Abscess | 1 | 1998 | 153 | 0.140 |
Why?
|
Diet Surveys | 2 | 2019 | 1160 | 0.130 |
Why?
|
Image Processing, Computer-Assisted | 4 | 2021 | 9015 | 0.130 |
Why?
|
Plasticizers | 1 | 2016 | 52 | 0.130 |
Why?
|
Lifting | 1 | 2017 | 56 | 0.130 |
Why?
|
Academic Medical Centers | 3 | 2017 | 2784 | 0.130 |
Why?
|
Diet, Mediterranean | 2 | 2020 | 748 | 0.130 |
Why?
|
Dicarboxylic Acids | 1 | 2016 | 75 | 0.130 |
Why?
|
Soy Foods | 1 | 2016 | 44 | 0.130 |
Why?
|
Models, Molecular | 1 | 2006 | 5403 | 0.130 |
Why?
|
Fallopian Tube Diseases | 1 | 2016 | 60 | 0.130 |
Why?
|
Infant, Newborn | 14 | 2024 | 26422 | 0.130 |
Why?
|
Poisson Distribution | 1 | 2017 | 506 | 0.130 |
Why?
|
Laparotomy | 1 | 1998 | 458 | 0.130 |
Why?
|
Fruit | 2 | 2019 | 1165 | 0.130 |
Why?
|
Vegetables | 2 | 2019 | 1199 | 0.130 |
Why?
|
Cyclohexanecarboxylic Acids | 1 | 2016 | 139 | 0.130 |
Why?
|
Oocyte Donation | 1 | 2016 | 52 | 0.130 |
Why?
|
Climate Change | 1 | 2022 | 509 | 0.130 |
Why?
|
Calcifediol | 1 | 2016 | 160 | 0.130 |
Why?
|
Sperm Motility | 3 | 2023 | 265 | 0.120 |
Why?
|
Seasons | 1 | 2021 | 1524 | 0.120 |
Why?
|
Testis | 1 | 2018 | 783 | 0.120 |
Why?
|
Thyroxine | 1 | 2018 | 665 | 0.120 |
Why?
|
Counseling | 1 | 2022 | 1554 | 0.120 |
Why?
|
Menotropins | 1 | 2014 | 41 | 0.120 |
Why?
|
Temperature | 1 | 2021 | 2234 | 0.120 |
Why?
|
Male | 40 | 2024 | 364719 | 0.110 |
Why?
|
Triglycerides | 1 | 2022 | 2464 | 0.110 |
Why?
|
Abdominal Injuries | 2 | 1996 | 362 | 0.110 |
Why?
|
von Hippel-Lindau Disease | 1 | 2015 | 154 | 0.110 |
Why?
|
Preservatives, Pharmaceutical | 1 | 2013 | 34 | 0.110 |
Why?
|
Wounds, Gunshot | 7 | 1996 | 586 | 0.110 |
Why?
|
Ureter | 1 | 1996 | 364 | 0.110 |
Why?
|
Cohort Studies | 11 | 2023 | 41754 | 0.110 |
Why?
|
Odds Ratio | 5 | 2018 | 9669 | 0.110 |
Why?
|
Dietary Fats | 2 | 2018 | 2003 | 0.110 |
Why?
|
Vehicle Emissions | 1 | 2018 | 651 | 0.110 |
Why?
|
Housing | 1 | 2018 | 683 | 0.110 |
Why?
|
Biological Products | 1 | 2022 | 948 | 0.110 |
Why?
|
Cholesterol | 1 | 2022 | 2914 | 0.100 |
Why?
|
Cross-Sectional Studies | 7 | 2024 | 26379 | 0.100 |
Why?
|
Caffeine | 1 | 2017 | 703 | 0.100 |
Why?
|
Work Schedule Tolerance | 1 | 2017 | 553 | 0.100 |
Why?
|
Risk Assessment | 6 | 2022 | 24315 | 0.100 |
Why?
|
Uterus | 1 | 2016 | 663 | 0.100 |
Why?
|
Urine | 1 | 2013 | 362 | 0.100 |
Why?
|
Wounds, Stab | 4 | 1995 | 72 | 0.090 |
Why?
|
Massachusetts | 6 | 2021 | 8890 | 0.090 |
Why?
|
Neurofibromatosis 2 | 1 | 2015 | 388 | 0.090 |
Why?
|
Antioxidants | 1 | 2019 | 1673 | 0.090 |
Why?
|
Young Adult | 14 | 2024 | 60066 | 0.090 |
Why?
|
Particulate Matter | 2 | 2020 | 2617 | 0.090 |
Why?
|
Weight Gain | 1 | 2021 | 2359 | 0.090 |
Why?
|
Ovarian Hyperstimulation Syndrome | 1 | 2010 | 47 | 0.090 |
Why?
|
Obesity | 2 | 2022 | 13090 | 0.090 |
Why?
|
Autoantibodies | 1 | 2018 | 2121 | 0.080 |
Why?
|
Ultrasonography | 3 | 2021 | 6004 | 0.080 |
Why?
|
Prevalence | 3 | 2014 | 15869 | 0.080 |
Why?
|
Time Factors | 8 | 2021 | 40218 | 0.080 |
Why?
|
Occupational Diseases | 1 | 2017 | 1457 | 0.080 |
Why?
|
Organ Size | 1 | 2013 | 2267 | 0.080 |
Why?
|
Prognosis | 4 | 2020 | 30010 | 0.070 |
Why?
|
Gestational Age | 4 | 2021 | 3621 | 0.070 |
Why?
|
Luteal Phase | 1 | 2008 | 138 | 0.070 |
Why?
|
Cesarean Section | 4 | 2024 | 1425 | 0.070 |
Why?
|
Nutritive Value | 2 | 2021 | 351 | 0.070 |
Why?
|
Prolactin | 1 | 2010 | 627 | 0.070 |
Why?
|
Leuprolide | 1 | 2009 | 313 | 0.070 |
Why?
|
Obstetric Labor, Premature | 3 | 2015 | 268 | 0.070 |
Why?
|
Regression Analysis | 1 | 2017 | 6340 | 0.070 |
Why?
|
Life Style | 1 | 2018 | 3932 | 0.070 |
Why?
|
Tuberous Sclerosis | 1 | 2015 | 1042 | 0.070 |
Why?
|
Vitamin D Deficiency | 1 | 2016 | 1388 | 0.070 |
Why?
|
Occupational Exposure | 1 | 2017 | 1807 | 0.070 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 12543 | 0.070 |
Why?
|
Metabolome | 2 | 2023 | 1009 | 0.060 |
Why?
|
Multivariate Analysis | 3 | 2019 | 12077 | 0.060 |
Why?
|
Spinal Neoplasms | 1 | 2012 | 715 | 0.060 |
Why?
|
Age Distribution | 2 | 2017 | 2873 | 0.060 |
Why?
|
Thrombosis | 1 | 2019 | 2957 | 0.060 |
Why?
|
Fellowships and Scholarships | 1 | 2014 | 1135 | 0.060 |
Why?
|
Diagnosis, Differential | 1 | 2020 | 13014 | 0.060 |
Why?
|
Comorbidity | 2 | 2022 | 10590 | 0.060 |
Why?
|
Tamoxifen | 1 | 2009 | 966 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2022 | 10399 | 0.060 |
Why?
|
Alcohol Drinking | 1 | 2017 | 4045 | 0.060 |
Why?
|
Nurses | 1 | 2014 | 2501 | 0.060 |
Why?
|
Reproduction | 2 | 2021 | 646 | 0.060 |
Why?
|
Algorithms | 3 | 2021 | 14164 | 0.060 |
Why?
|
Sulfonic Acids | 1 | 2024 | 103 | 0.060 |
Why?
|
COS Cells | 1 | 2006 | 1135 | 0.060 |
Why?
|
Radiography | 2 | 2010 | 6983 | 0.060 |
Why?
|
Decision Making | 1 | 1998 | 3953 | 0.060 |
Why?
|
Colon | 3 | 1996 | 1801 | 0.060 |
Why?
|
Adolescent | 15 | 2021 | 89169 | 0.050 |
Why?
|
Middle Aged | 19 | 2021 | 223492 | 0.050 |
Why?
|
Micromanipulation | 1 | 2022 | 53 | 0.050 |
Why?
|
Analysis of Variance | 3 | 2010 | 6229 | 0.050 |
Why?
|
Phenotype | 1 | 2021 | 16726 | 0.050 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2006 | 1683 | 0.050 |
Why?
|
Nutritional Status | 2 | 2021 | 1628 | 0.050 |
Why?
|
Hypertension | 1 | 2022 | 8616 | 0.050 |
Why?
|
Family Characteristics | 2 | 2018 | 1003 | 0.050 |
Why?
|
Ploidies | 1 | 2023 | 287 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 1 | 2010 | 36743 | 0.050 |
Why?
|
Vitamins | 2 | 2023 | 1638 | 0.050 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2009 | 1099 | 0.050 |
Why?
|
Patient Acceptance of Health Care | 1 | 2016 | 3231 | 0.050 |
Why?
|
Environmental Monitoring | 2 | 2019 | 1469 | 0.050 |
Why?
|
Men | 1 | 2021 | 64 | 0.050 |
Why?
|
Confidence Intervals | 2 | 2004 | 2923 | 0.050 |
Why?
|
Testosterone | 2 | 2023 | 2491 | 0.050 |
Why?
|
Phenol | 1 | 2021 | 45 | 0.050 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2009 | 1536 | 0.050 |
Why?
|
Hair | 1 | 2004 | 508 | 0.050 |
Why?
|
Age Factors | 2 | 2016 | 18412 | 0.040 |
Why?
|
Registries | 2 | 2016 | 8375 | 0.040 |
Why?
|
Watchful Waiting | 1 | 2024 | 492 | 0.040 |
Why?
|
Enzyme Activation | 1 | 2006 | 3590 | 0.040 |
Why?
|
Body Weight | 1 | 2010 | 4627 | 0.040 |
Why?
|
Sweetening Agents | 1 | 2022 | 290 | 0.040 |
Why?
|
Exercise | 1 | 2016 | 5955 | 0.040 |
Why?
|
Statistics, Nonparametric | 1 | 2005 | 2862 | 0.040 |
Why?
|
Probability | 1 | 2004 | 2479 | 0.040 |
Why?
|
Aneuploidy | 1 | 2023 | 573 | 0.040 |
Why?
|
Weights and Measures | 1 | 2018 | 40 | 0.040 |
Why?
|
Diet Records | 1 | 2020 | 426 | 0.040 |
Why?
|
Hyperemesis Gravidarum | 1 | 1998 | 24 | 0.040 |
Why?
|
Colostomy | 2 | 1996 | 106 | 0.040 |
Why?
|
Fetal Death | 1 | 2000 | 434 | 0.040 |
Why?
|
Sterilization, Tubal | 1 | 2018 | 78 | 0.040 |
Why?
|
Fetal Growth Retardation | 2 | 2013 | 592 | 0.040 |
Why?
|
Waist Circumference | 1 | 2022 | 935 | 0.040 |
Why?
|
Eicosapentaenoic Acid | 1 | 2022 | 565 | 0.040 |
Why?
|
Cell Count | 1 | 2021 | 1832 | 0.040 |
Why?
|
Follow-Up Studies | 5 | 2018 | 39348 | 0.040 |
Why?
|
Delivery, Obstetric | 2 | 2012 | 954 | 0.040 |
Why?
|
Nitrogen Dioxide | 1 | 2020 | 534 | 0.040 |
Why?
|
New England | 1 | 2020 | 1058 | 0.040 |
Why?
|
Binding Sites | 1 | 2006 | 6020 | 0.040 |
Why?
|
Intrauterine Devices | 1 | 2018 | 115 | 0.040 |
Why?
|
Androgens | 1 | 2004 | 1281 | 0.040 |
Why?
|
Methylprednisolone | 1 | 1998 | 386 | 0.030 |
Why?
|
Dystocia | 1 | 1997 | 36 | 0.030 |
Why?
|
Beverages | 1 | 2022 | 819 | 0.030 |
Why?
|
Thoracotomy | 2 | 1995 | 374 | 0.030 |
Why?
|
Immunoglobulins, Thyroid-Stimulating | 1 | 2016 | 34 | 0.030 |
Why?
|
Recombinant Proteins | 1 | 2006 | 6514 | 0.030 |
Why?
|
Patient Selection | 1 | 2008 | 4260 | 0.030 |
Why?
|
Progesterone | 1 | 2020 | 752 | 0.030 |
Why?
|
Pesticides | 1 | 2019 | 298 | 0.030 |
Why?
|
Hospitalization | 2 | 2015 | 10840 | 0.030 |
Why?
|
Phytoestrogens | 1 | 2016 | 59 | 0.030 |
Why?
|
Self Report | 2 | 2018 | 3773 | 0.030 |
Why?
|
Fatty Acids | 1 | 2023 | 1812 | 0.030 |
Why?
|
Postoperative Complications | 1 | 1998 | 15832 | 0.030 |
Why?
|
Immunoenzyme Techniques | 1 | 2018 | 1703 | 0.030 |
Why?
|
Microscopy | 1 | 2020 | 909 | 0.030 |
Why?
|
Docosahexaenoic Acids | 1 | 2022 | 914 | 0.030 |
Why?
|
Research | 1 | 2023 | 1979 | 0.030 |
Why?
|
Genes, Neurofibromatosis 1 | 1 | 2014 | 74 | 0.030 |
Why?
|
Subclavian Vein | 1 | 1994 | 57 | 0.030 |
Why?
|
Medical Staff | 1 | 2014 | 40 | 0.030 |
Why?
|
Colectomy | 2 | 1996 | 696 | 0.030 |
Why?
|
Demography | 1 | 2018 | 1641 | 0.030 |
Why?
|
Shock | 1 | 1996 | 316 | 0.030 |
Why?
|
Protein Binding | 1 | 2006 | 9343 | 0.030 |
Why?
|
Pylorus | 1 | 1993 | 86 | 0.030 |
Why?
|
Vena Cava, Inferior | 1 | 1996 | 463 | 0.030 |
Why?
|
Subclavian Artery | 1 | 1994 | 138 | 0.030 |
Why?
|
Neck Injuries | 1 | 1994 | 162 | 0.030 |
Why?
|
Metabolomics | 1 | 2022 | 1674 | 0.030 |
Why?
|
Leadership | 1 | 2022 | 1397 | 0.030 |
Why?
|
Anastomosis, Surgical | 1 | 1996 | 991 | 0.030 |
Why?
|
Thoracic Injuries | 1 | 1995 | 288 | 0.030 |
Why?
|
Lipids | 1 | 2023 | 3343 | 0.030 |
Why?
|
Computer Simulation | 1 | 2006 | 6283 | 0.030 |
Why?
|
Intraoperative Care | 1 | 1996 | 770 | 0.030 |
Why?
|
Heart Injuries | 1 | 1994 | 207 | 0.020 |
Why?
|
Enteral Nutrition | 1 | 1998 | 802 | 0.020 |
Why?
|
Hot Temperature | 1 | 2018 | 1441 | 0.020 |
Why?
|
Animals | 4 | 2024 | 169246 | 0.020 |
Why?
|
United States | 4 | 2024 | 73039 | 0.020 |
Why?
|
Medical Records | 1 | 2017 | 1410 | 0.020 |
Why?
|
Forecasting | 2 | 2000 | 2945 | 0.020 |
Why?
|
Nephrectomy | 1 | 1996 | 930 | 0.020 |
Why?
|
Workload | 1 | 2017 | 849 | 0.020 |
Why?
|
Ambulatory Care Facilities | 1 | 2017 | 939 | 0.020 |
Why?
|
Brain Neoplasms | 1 | 2012 | 9118 | 0.020 |
Why?
|
Duodenum | 1 | 1993 | 495 | 0.020 |
Why?
|
Neck | 1 | 1994 | 736 | 0.020 |
Why?
|
Ambulatory Care | 1 | 2021 | 2783 | 0.020 |
Why?
|
Intraoperative Complications | 1 | 1996 | 1171 | 0.020 |
Why?
|
Child | 6 | 2024 | 80917 | 0.020 |
Why?
|
Public Health | 1 | 2022 | 2679 | 0.020 |
Why?
|
Double-Blind Method | 2 | 2020 | 12465 | 0.020 |
Why?
|
Survival Rate | 4 | 2012 | 12840 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2004 | 15454 | 0.020 |
Why?
|
Wounds and Injuries | 1 | 2000 | 2517 | 0.020 |
Why?
|
Reoperation | 1 | 1998 | 4329 | 0.020 |
Why?
|
Ultrasonography, Mammary | 1 | 2009 | 243 | 0.020 |
Why?
|
Sex Factors | 1 | 2021 | 10632 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2019 | 3573 | 0.020 |
Why?
|
Infant | 2 | 2021 | 36535 | 0.020 |
Why?
|
Spinal Cord Injuries | 1 | 1995 | 928 | 0.020 |
Why?
|
Preoperative Care | 1 | 1996 | 2258 | 0.020 |
Why?
|
International Classification of Diseases | 1 | 2013 | 937 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2004 | 22291 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2004 | 15948 | 0.020 |
Why?
|
Incidence | 1 | 2024 | 21538 | 0.020 |
Why?
|
Faculty, Medical | 1 | 2014 | 1226 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2021 | 19015 | 0.020 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2009 | 737 | 0.010 |
Why?
|
Mastectomy, Segmental | 1 | 2009 | 974 | 0.010 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2009 | 1791 | 0.010 |
Why?
|
Hemorrhage | 1 | 1996 | 3467 | 0.010 |
Why?
|
Wound Infection | 2 | 1996 | 243 | 0.010 |
Why?
|
Lymph Node Excision | 1 | 2009 | 1271 | 0.010 |
Why?
|
Secondary Prevention | 1 | 2009 | 1474 | 0.010 |
Why?
|
Models, Statistical | 1 | 2016 | 5107 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2009 | 21206 | 0.010 |
Why?
|
Androstane-3,17-diol | 1 | 2001 | 20 | 0.010 |
Why?
|
Absorption | 1 | 2001 | 244 | 0.010 |
Why?
|
Cheek | 1 | 2001 | 66 | 0.010 |
Why?
|
Receptors, Estrogen | 1 | 2009 | 2253 | 0.010 |
Why?
|
Abbreviated Injury Scale | 1 | 2000 | 49 | 0.010 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2009 | 3556 | 0.010 |
Why?
|
Dihydrotestosterone | 1 | 2001 | 195 | 0.010 |
Why?
|
Fetal Monitoring | 1 | 2000 | 70 | 0.010 |
Why?
|
Gels | 1 | 2001 | 423 | 0.010 |
Why?
|
Monitoring, Physiologic | 2 | 2000 | 1798 | 0.010 |
Why?
|
South Africa | 2 | 1996 | 1873 | 0.010 |
Why?
|
Administration, Cutaneous | 1 | 2001 | 716 | 0.010 |
Why?
|
Promethazine | 1 | 1998 | 29 | 0.010 |
Why?
|
Ovariectomy | 1 | 2001 | 613 | 0.010 |
Why?
|
Receptor, erbB-2 | 1 | 2009 | 2603 | 0.010 |
Why?
|
Mammography | 1 | 2009 | 2433 | 0.010 |
Why?
|
Glasgow Coma Scale | 1 | 2000 | 574 | 0.010 |
Why?
|
Aging | 1 | 2017 | 8744 | 0.010 |
Why?
|
Likelihood Functions | 1 | 2000 | 994 | 0.010 |
Why?
|
Injury Severity Score | 1 | 2000 | 1049 | 0.010 |
Why?
|
Shock, Traumatic | 1 | 1996 | 22 | 0.010 |
Why?
|
Pregnancy in Diabetics | 1 | 1997 | 198 | 0.010 |
Why?
|
Brachial Plexus | 1 | 1997 | 171 | 0.010 |
Why?
|
Shoulder | 1 | 1997 | 300 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2009 | 11244 | 0.010 |
Why?
|
Multiple Trauma | 1 | 1996 | 369 | 0.010 |
Why?
|
Methods | 1 | 1993 | 1066 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2009 | 9538 | 0.010 |
Why?
|
Sternum | 1 | 1994 | 177 | 0.010 |
Why?
|
Administration, Oral | 1 | 2001 | 4030 | 0.010 |
Why?
|
Postpartum Hemorrhage | 1 | 1997 | 275 | 0.010 |
Why?
|
Rectum | 1 | 1997 | 900 | 0.010 |
Why?
|
Abscess | 1 | 1995 | 606 | 0.010 |
Why?
|
Blood Vessels | 1 | 1996 | 1110 | 0.010 |
Why?
|
Mutation | 1 | 2014 | 30238 | 0.010 |
Why?
|
Hemodynamics | 1 | 2000 | 4194 | 0.010 |
Why?
|
Cause of Death | 1 | 2000 | 3721 | 0.010 |
Why?
|
Accidents, Traffic | 1 | 1995 | 818 | 0.010 |
Why?
|
Morbidity | 1 | 1994 | 1755 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2015 | 15662 | 0.000 |
Why?
|
Emergencies | 1 | 1995 | 1221 | 0.000 |
Why?
|
Wounds, Nonpenetrating | 1 | 1995 | 807 | 0.000 |
Why?
|
Pilot Projects | 1 | 2001 | 8741 | 0.000 |
Why?
|
Recurrence | 1 | 1998 | 8509 | 0.000 |
Why?
|
Fractures, Bone | 1 | 1997 | 2062 | 0.000 |
Why?
|
Length of Stay | 1 | 1995 | 6498 | 0.000 |
Why?
|
Emergency Service, Hospital | 1 | 1995 | 7951 | 0.000 |
Why?
|